96736 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids
Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
#3602Polypeptides and use thereof
#3603Use of endostatin peptides for the treatment of fibrosis
#3604Influenza inhibiting compositions and methods
#3605α4β7 peptide dimer antagonists
#3606Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
#3607Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
#3608Mirac proteins
#3609Precipitable peptides
#3610Template-fixed peptidomimetics with antimicrobial activity
#3611Template-fixed peptidomimetics with antimicrobial activity
#3612Methods and compositions for detecting and modulating O-glycosylation
#3613PEPTIDE FOR VACCINE
#3614Macromolecule transduction domains and methods for identification and uses thereof
#3615Beta sheet tapes ribbons in tissue engineering
#3616Peptide Conjugates and Fluorescence Detection Methods for Intracellular Caspase Assay
#3617TREATMENT OF ATHEROSCLEROSIS WITH CHOLESTEROL ESTER TRANSPORT PROTEIN MIMOTOPES
#3618Substituted piperazin-2,5-diones as multifunctional bioactive compounds
#3619Peptides that stimulate subcutaneous adipogenesis
#3620Compounds containing a vascular disrupting agent
#3621Cell proliferation-promoting peptide and use thereof
#3622Antigen peptide and uses thereof
#3623Retrograde transport peptide and use of same for delivery to central nervous system
#3624Antibody-like proteins for therapeutic and diagnostic use
#3625Peptide inhibitors of protein kinase C
#3626Protection of cells from -RNA-induced degeneration and inhibitors for protecting cells
#3627Fusion proteins forming trimers
#3628PEPTIDE-CROSSLINKED BIOACTIVE POLYMERIC MATERIALS
#3629NOVEL PEPTIDES THAT ENHANCE TIGHT JUNCTION PERMEABILITY
#3630Compositions and methods related to tauopathy
#3631Process for preparing eptifibatide
#3632Amphipathic peptide-lipase conjugate having advanced lipase activity and use thereof
#3633Therapeutic compositions and related methods
#3634METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES
#3635Molecular imaging of cancer cells in vivo
#3636F11 receptor (F11R) antagonists as therapeutic agents
#3637Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides
#3638Antimicrobial compositions and methods of use thereof
#3639Peptides and compositions for prevention of cell adhesion and methods of using same
#3640Selectively targeted antimicrobial peptides and the use thereof
#3641Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
#3642Compound and method for modulating opioid receptor activity
#3643Chemokine binding polypeptides for treating autoimmunity and inflammation
#3644Compositions and methods for modulating gamma-c-cytokine activity
#3645Amidated dopamine neuron stimulating peptides for CNS dopaminergic upregulation
#3646ANTIBACTERIAL PEPTIDES
#3647Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
#3648Macrocyclic broad spectrum antibiotics
#3649HLA-A2 tumor associated antigen peptides and compositions
#3650Melk epitope peptides and vaccines containing the same
#3651Peptide vaccines for cancers expressing tumor-associated antigens
#3652Immunogenic peptides and methods of use for treating and preventing cancer
#3653CHEMICALLY MODIFIED CELL-PENETRATING PEPTIDES FOR IMPROVED DELIVERY OF GENE MODULATING COMPOUNDS
#3654Peptides and methods using same
#3655Lipopeptide inhibitors of RAS oncoproteins
#3656NOVEL ZINC FINGER-LIKE PEPTIDE COMPOSITIONS AS POTENT AGENTS IN CANCER PREVENTION AND TREATMENT
#3657Screening methods for identifying proteases inhibitors
#3658Method for transforming a bacterium belonging to the genus by natural competence
#3659EphA2 T-cell epitope agonists and uses therefore
#3660Modified plant defensins useful as anti-pathogenic agents
#3661PEPTIDE ANTAGONISTS OF ZONULIN AND METHODS FOR USE OF THE SAME
#3662METHOD AND USE OF PEPTIDE ANTAGONISTS OF ZONULIN TO PREVENT OR DELAY THE ONSET OF DIABETES
#3663Antimicrobial peptides and uses therefore
#3664Anti-Inflammatory Peptide Derived From Thrombospondin-1 and Uses Thereof
#3665Compositions and methods for treating AIDS or cancer by inhibiting the secretion of microparticles
#3666ANTAGONISTS OF TRPV1 RECEPTOR
#3667Induction of the mitochondrial permeability transition
#3668Peptides useful in the treatment and care of the skin and mucous membranes and their use in cosmetic or pharmaceutical compositions
#3669Use of peptides for promoting wound healing
#3670Modification of peptides via SAr reactions of thiols with fluorinated aromatics
#3671Peptide for inhibition of binding between angiopoietin-2 and integrin and use thereof
#3672Cyclic peptides with an anti-neoplasic and anti-angiogenic activity
#3673Polypeptide inhibitors of HSP27 kinase and uses therefor
#3674Melanocortin 1 receptor ligands and methods of use
#3675PROCESSES AND INTERMEDIATES
#3676Selective targeting agents for mitochondria
#3677Polycomb repressive complex 2 (PRC2) inhibitors and uses thereof
#3678Template-fixed peptidomimetics
#3679Stabilized bioactive peptides and methods of identification, synthesis, and use
#3680Prodrugs of Peptide Epoxy Ketone Protease Inhibitors
#3681Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates
#3682PEPTOID COMPOSITIONS AND METHODS OF USING THE SAME
#3683Aldehyde acetal based processes for the manufacture of macrocyclic depsipeptides and new intermediates
#3684Plant-derived elastin binding protein ligands and methods of using the same
#3685Prodrugs of peptide epoxy ketone protease inhibitors
#3686Combination therapy and kit for the prevention and treatment of cystic fibrosis
#3687Prodrugs of peptide epoxy ketone protease inhibitors
#3688Methods for assaying enzyme activities
#3689HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide
#3690High-affinity, dimeric inhibitors of PSD-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain
#3691COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASE INCLUDING BIOACTIVE PEPTIDE AS EFFECTIVE COMPONENT
#3692ANTAGONIST FOR (PRO)RENIN RECEPTOR FOR THE TREATMENT OF HYPERTENSION AND DIABETES
#3693Angiotensin Type 2 (AT2) receptor agonists and uses thereof
#3694Marker comprising anti-CK8/18 complex autoantibody and its use for diagnosing cancer
#3695Therapeutic DLL4 binding proteins
#3696Amphiphilic linear peptidepeptoid and hydrogel comprising the same
#3697Melanoma antigen peptide and uses thereof
#3698sGCalphal inhibiting compositions
#3699USE OF AKT PHOSPHORYLATION AS A BIOMARKER FOR PROGNOSING NEURODEGENERATIVE DISEASES AND TREATING SAME
#3700Template-fixed peptidomimetics with antimicrobial activity
#3701PGC-1α-modulating peptides
#3702Albumin-amyloid peptide conjugates and uses thereof
#3703Delivery system for cytotoxic drugs by bispecific antibody pretargeting
#3704Skin or hair binding peptides
#3705Processes for the manufacture of macrocyclic depsipeptides and new intermediates
#3706HYD1 PEPTIDES FOR RELAPSED CANCER
#3707BMP BINDING PEPTIDES
#3708Stabilized calcium phosphate complexes
#3709Antagonists of the interleukin-1 receptor
#3710Method of treating eosinophilia by administering an immunomodulating peptide
#3711Antibody specifically recognizing an epitope for switching to Th2 cell and a method for converting T cell to type 2 helper T cell using the same
#3712Monoclonal antibody specifically recognizing an epitope for switching to Th17 cell
#3713BINDING LIGAND LINKED DRUG DELIVERY CONJUGATES OF TUBULYSINS
#3714Functionalized biomaterials for tissue regeneration
#3715Peptides that are modulators of the protein TRF2 and compositions containing same
#3716Peptides and use thereof in the inhibition of angiotensin converting enzyme
#3717Carrier peptides for cell delivery
#3718Antibody specifically recognizing an epitope for switching to T1 cell
#3719Compositions of A-8R peptide
#3720Treatment of cancers with A-8R peptide
#3721Adiponectin receptor agonists and methods of use
#3722Small peptide modulators of potassium channel trafficking
#3723Bisubstrate fluorescent probes for protein kinase CK2
#3724Anti-inflammatory antibodies and uses therefor
#3725LLP2A-bisphosphonate conjugates for osteoporosis treatment
#3726INHIBITORS OF SERINE PROTEASES
#3727Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
#3728Synthetic peptide that induces expression of TNF receptor 2 and use thereof
#3729Mesothelin vaccines and model systems
#3730MHC-I restricted epitopes containing non-natural amino acid residues
#3731Prostate specific antigen agents and methods of using same for prostate cancer imaging
#3732NOVEL DIPEPTIDYL PEPTIDASE IV (DP-IV) COMPOUNDS
#3733Hydrogen bond surrogate macrocycles as modulators of Ras
#3734Tight junction protein modulators and uses thereof
#3735Methods of protecting against apoptosis using lipopeptides
#3736METHODS FOR INCREASING AND MOBILIZING HEMATOPOIETIC STEM CELLS
#3737Compositions and methods for coronavirus inhibition
#3738Fusion protein
#3739Nanoparticles containing pH-responsive peptide
#3740TDF-related compounds and analogs thereof
#3741ALZHEIMER'S DISEASE TREATMENT METHOD
#3742Molecular marker for cancer stem cell
#3743Activator peptides for synthesizing extracellular matrix proteins, and cosmetic compositions including same
#3744Beta sheet tapes ribbons in tissue engineering
#3745AMYLOID-BETA PEPTIDE CRYSTAL STRUCTURE
#3746Tissue occluding agent comprising an IEIKIEIKIEIKI peptide
#3747Peptides for suppressing inflammation
#3748Compositions and methods for promoting wound healing and tissue regeneration
#3749MAPKAP kinase-2 as a specific target for blocking proliferation of P53-defective
#3750Metal Abstraction Peptide With Release of Metal
#3751Pharmaceutical Compositions Comprising Antibodies Binding To EBV (Ebstein-Barr Virus) Protein BARF1
#3752Peptides involved in the SCF c-Kit signaling pathway and compositions comprising same
#3753Peptidic activators of type I cGMP dependent protein kinases and uses thereof
#3754Selective Poly-N-Substituted Glycine Antibiotics
#3755Therapeutic agents with improved fibrinogen binding
#3756Antifungal composition comprising polycyclic peptide compound and method for preparing the same
#3757Modified antibody compositions, methods of making and using thereof
#3758Peptidomimetics comprising N-amino cyclic urea residues and uses thereof
#3759DISEASE INHIBITING AGENT
#3760Cyclic peptide and conjugate thereof for binding to keratinocytes
#3761TOMM34 peptides and vaccines including the same
#3762Cancer vaccine composition
#3763Neuroprotective and neurorestorative methods and compositions
#3764Stitched polypeptides
#3765Cyclic peptides, their preparation and their use as inhibitors of the platelet adhesion
#3766Melanocortin receptor ligands modified with hydantoin
#3767Branched chain-containing aromatic compound
#3768COMPOSITIONS AND METHODS FOR TREATING AIDS OR CANCER BY INHIBITING THE SECRETION OF MICROPARTICLES
#3769β-arrestin effectors and compositions and methods of use thereof
#3770Bioactive peptides and methods of using same
#3771IMMUNE RESTRICTED PEPTIDES WITH INCREASED EFFICACY
#3772MIA (Melanoma Inhibitory Activity) Inhibitors for Detecting, Preventing and Curing Vitiligo
#3773Stable and soluble antibodies inhibiting VEGF
#3774NPR-B agonists
#3775Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
#3776Modulators for SIRT6 and assays for screening same
#3777Methods of treating ophthalmic diseases using NPR-B agonists
#3778Peptide-phospholipid conjugates
#3779Factor H binding peptides and uses thereof
#3780Methods and compositions related to internalizing RGD peptides
#3781Mucin hypersecretion inhibitors and methods of use
#3782Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#3783Methods and compositions for the treatment of axonal and neuronal degeneration
#3784Salts and Polymorphs of Sulfamide NS3 Inhibitors
#3785Use of ide as a biomarker for a scalp condition
#3786Drug transporter permeating blood-brain barrier, peptide and use thereof
#3787BIOMIMETIC PEPTIDES FOR BONE AUGMENTATION
#3788Anti-ageing peptides modulating survivin and compositions including same
#3789PAR1 and PAR2 c-tail peptides and peptide mimetics
#3790Nitrated cardiac troponin I as a biomarker of cardiac ischemia
#3791METHODS FOR INCREASING INSULIN SENSITIVITY AND TREATING DIABETES WITH A BIOACTIVE CHROMIUM BINDING PEPTIDE
#3792Eye drop composition for prevention and treatment of ophthalmic diseases containing fusion protein of FK506 binding protein
#3793AGENTS FOR INCREASED RESISTANCE AGAINST OXIDATIVE STRESS CONDITIONS
#3794Peptide adjuvants
#3795SYNTHETIC PEPTIDES FOR USE AS INHIBITORS OF NEUROTRANSMITTER SECRETION AND AS INDUCERS OF CELLULAR RELAXATION
#3796AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#3797NUCLEIC ACIDS ENCODING PEPTIDES FOR TREATING WOUNDS, ANTI-ANGIOGENIC COMPOUNDS AND USES THEREOF
#3798Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same
#3799Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#3800Respiratory syncytial virus vaccine
#3801Conjugates for the treatment of mesothelioma
#3802Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides
#3803Glycogen synthase kinase-3 inhibitors
#3804WDHD1 peptides and vaccines including the same
#3805Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
#3806Ligand and metal complex having the same
#3807Cell-protective peptides and uses thereof
#3808Glycogen synthase kinase-3 inhibitors
#3809CHIMERIC PEPTIDES INCLUDING A PENETRATING PEPTIDE AND A BINDING DOMAIN OF PP2A CATALYTIC SUBUNIT TO CASPASE-9
#3810Smart pro-drugs of serine protease inhibitors
#3811Intestinal peptide targeting ligands
#3812Use of peptides for promoting wound healing
#3813MUC18 TARGETING PEPTIDES
#3814METHOD FOR TREATMENT OF PSORIASIS
#3815METHODS AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISORDERS
#3816METHOD FOR TREATMENT OF INFLAMMATORY DISEASE AND DISORDER
#3817Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
#3818PAR4 agonist peptides
#3819Dermatopontin-activating peptides and cosmetic compositions including same
#3820Use of peptides for promoting wound healing
#3821Anticancer fusion protein comprising trail and a growth factor receptor inhibitor
#3822Methods for treating steatotic disease
#3823SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same
#3824COMPOUNDS FOR TREATING SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE
#3825Process for the manufacture of Degarelix and its intermediates
#3826Process for the manufacture of Degarelix and its intermediates
#3827Detection of degradative enzymes and biomolecules in bodily fluids
#3828Larazotide acetate compositions
#3829Broad spectrum antibiotic arylomycin analogs
#3830SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF
#3831Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
#3832Compositions and methods for promoting wound healing and tissue regeneration
#3833Peptides for treating cancer
#3834Selective anticancer chimeric peptides which bind neuropilin receptor
#3835Selective anticancer chimeric peptides which bind transferrin receptor
#3836Active cores of peptide triazole HIV-1 entry inhibitors
#3837Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
#3838β-arrestin effectors and compositions and methods of use thereof
#3839Antigen-Norovirus P-domain monomers and dimers, antigen Norovirus P-particle molecules, and methods for their making and use
#3840Treatment of penetrative injury to the brain
#3841PEPTIDE CONTAINING MULTIPLE N-LINKED GLYCOSYLATION SEQUONS
#3842Small cationic antimicrobial peptides
#3843Moesin modulators and uses thereof
#3844TREATMENT OF INFLAMMATORY BOWEL DISEASES USING A TRIPEPTIDE
#3845PEPTIDES
#3846CLASS I MHC PHOSPHOPEPTIDES FOR CANCER IMMUNOTHERAPY AND DIAGNOSIS
#3847Compounds and methods for treating or preventing disease conditions associated with α-1-antitrypsin
#3848Peptides of syndecan-1 for inhibit angiogenesis
#3849BONE MARROW APLASIA WITH HAEMORRHAGIC DISEASE IN CALVES CAUSED BY NOVEL PATHOGEN
#3850Ligands to radiation-induced molecules
#3851Polynucleotide for use in treatment of influenza A virus induced diseases, encoding modified Mx protein, said modified Mx protein, and a transgenic animal expressing gene encoding modified Mx protein
#3852Methods and compositions related to improving properties of pharmacological agents targeting nervous system
#3853Compositions for treatment of neurodegenerative diseases
#3854VIP fragments and methods of use
#3855Antimicrobial peptides and derived metapeptides
#3856Molecules mimicking an autoantibody idiotype and compositions containing same
#3857HIGH-EFFICIENCY CATALYSTS, PREPARATION AND USE THEREOF
#3858Polypeptides with affinity for heat shock proteins (HSPS) and HSP associated complexes (HACS) and their use in diagnosis and therapy
#3859TRPV1 inhibitory peptides and composition for skin-aging protection or wrinkle improvement comprising the same
#3860MULTIMODALITY AGENTS FOR TUMOR IMAGING AND THERAPY
#3861Cell-permeable peptide
#3862Melanocortin receptor-specific peptides
#3863Enzyme substrate comprising a functional dye and associated technology and methods
#3864Synthetic analogues of neural regeneration peptides
#3865Methods for selective targeting
#3866Peptide for use as a medicament, in particular for the treatment of cancer
#3867Immunostimulatory method
#3868PEPTIDE CAPABLE OF BINDING TO IMMUNOGLOBULIN
#3869Antidiabetic compounds
#3870Antimicrobial peptides
#3871REAGENTS AND METHODS FOR DETECTING PROTEIN CROTONYLATION
#3872Zinc-responsive peptides, and methods of use thereof
#3873ESTROGEN RECEPTOR ALPHA POLYPEPTIDE SEQUENCE, DIAGNOSTIC AND THERAPEUTIC APPLICATIONS THEREOF
#3874Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
#3875BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE
#3876Compositions and methods for modulating γ-c-cytokine activity
#3877ErbB interface peptidomimetics and methods of use thereof
#3878Linear peptide antibiotics
#3879Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof
#3880VACCINE COMPOSITION COMPRISING AN ANTIGEN AND A PEPTIDE HAVING ADJUVANT PROPERTIES
#3881Avian group D rotavirus
#3882Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
#3883Immunotoxin fusion proteins and means for expression thereof
#3884Pharmaceutical Compositions of Growth Hormone Secretagogue Receptor Ligands
#3885PEPTIDES, CONSTRUCTS AND USES THEREFOR
#3886METHOD AND PEPTIDE FOR REGULATING CELLULAR ACTIVITY
#3887Immunoregulatory peptides and methods of use
#3888Production and use of antitumoral antibiotic and insecticidal cyclodepsipeptides
#3889CXCR4 receptor compounds
#3890PENTAPEPTIDE DERIVATIVES FOR PROMOTING HAIR GROWTH
#3891IL-13 receptor binding peptides
#3892ANTI-VIRAL AGENT
#3893Azapeptides as CD36 binding compounds
#3894PROTEASE TARGETING AGENTS
#3895Immunoregulatory peptides and methods of use
#3896Immunoregulatory peptides and methods of use
#3897Bioactive peptide
#3898Mini-Hepcidin Peptides and Methods of Using Thereof
#3899Cyclic peptide compound, method for producing same, anti-infective agent, antibiotic-containing fraction, antibiotic, method for producing antibiotic, antibiotic-producing microorganism, and antibiotic produced by same
#3900Inhibitors of TLR signaling by targeting TIR domain interfaces